<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04516889</url>
  </required_header>
  <id_info>
    <org_study_id>Protocol V4.0</org_study_id>
    <nct_id>NCT04516889</nct_id>
  </id_info>
  <brief_title>Evaluating Safety and Efficacy of a Modified Technique of Scleral Fixation Intraocular Lens Implantation</brief_title>
  <official_title>Evaluating Safety and Efficacy of a Modified Technique of Scleral Fixation Intraocular Lens Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cataract is the leading cause of blindness globally and cataract surgery with the&#xD;
      implantation of intraocular lens (IOL) is the most commonly performed operation worldwide.&#xD;
      After removal of the cataract, an IOL is usually implanted within the capsular bag. However,&#xD;
      endocapsular implantation of IOL is not always feasible due to inadequate zonular or capsular&#xD;
      support, intraoperative posterior capsule rupture, or in primary intracapsular cataract&#xD;
      extraction. Predisposing factors including prior ocular trauma, intravitreal injection or&#xD;
      intraocular surgery, co-existing ocular comorbidities like chronic uveitis, pseudoexfoliation&#xD;
      syndrome, may increase the risk of failure of in-the-bag implantation.&#xD;
&#xD;
      In such situation, the surgeons may consider implanting the IOL in the anterior chamber,&#xD;
      ciliary sulcus, or using fixation techniques. In Asian eyes, the anterior chambers are often&#xD;
      shallow and placement in anterior chamber may accelerate corneal endothelial cell loss&#xD;
      leading to corneal decompensation, or worsen pre-existing glaucoma. Placement in the ciliary&#xD;
      sulcus depends on the amount and integrity of the capsular remnant, and inadequate support&#xD;
      may result in dislocation of the IOL. In recent years, newer forms of scleral fixation of IOL&#xD;
      using glue or glue-less approach, although these procedure appeared to be simpler, the&#xD;
      long-term stability of these IOL have not been evaluated against conventional approach with&#xD;
      suture fixation. The main limitations of suture fixation technique are related to the sutures&#xD;
      either intraoperatively (e.g. entanglement, failure to rotate and bury the suture knot) or&#xD;
      postoperatively (breakage, dissolution of suture with time), and the learning curve required&#xD;
      for surgeons in training.&#xD;
&#xD;
      Our study aims to study the efficacy and safety of a modified technique of scleral fixation&#xD;
      of an intraocular lens in the posterior chamber.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of eyes with intraoperative, early (within 1 week) and late (at 12 months) postoperative complications following this modified technique of intraocular lens fixation.</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Complication Rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Unaided and corrected visual acuities</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Visual acuities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraocular lens tilting</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Anterior segment optical coherence tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>endothelial cell status</measure>
    <time_frame>up to 12 months</time_frame>
    <description>specular microscopy</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">39</enrollment>
  <condition>Aphakia</condition>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention arm will undergo the modified sutured SFIOL technique with double Prolene sutures instead of a single Prolene suture</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Doubled sutured SFIOL</intervention_name>
    <description>Recruited subjects would undergo implantation of SFIOL with the modified technique under either local or general anesthesia. The surgeon would mark the sclerotomies as per routine sutured SFIOL at 2mm behind the nasal and temporal limbus, followed by passage of 2 pairs of prolene sutures. The intraocular lens with islets would be implanted into the posterior chamber and sutured to the sclera as per single suture SFIOL.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients with phacodonesis, lens subluxation, insufficient capsular or zonular&#xD;
             support, or surgical aphakia without adequate ciliary sulcus who are listed for&#xD;
             scleral fixation intraocular lens implantation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with previous corneal transplantation surgery or undergoing concomitant&#xD;
             corneal transplantation at the time of scleral fixation intraocular lens implantation.&#xD;
&#xD;
          -  Patients undergoing concomitant vitreoretinal surgery at the time of intraocular lens&#xD;
             implantation.&#xD;
&#xD;
          -  Monocular patients, or patients whose fellow eye had vision of equal or less than&#xD;
             20/200.&#xD;
&#xD;
          -  Patients who could not comprehend the risks and benefits of the surgery and/or the&#xD;
             research study, including mentally incapacitated persons.&#xD;
&#xD;
          -  Patients with pre-existing macular pathologies including macular oedema, haemorrhage,&#xD;
             degeneration or scar.&#xD;
&#xD;
          -  Patients with pre-existing iris abnormalities including aniridia, corectopia,&#xD;
             extensive anterior synechiae formation resulting in inability to measure the IOL&#xD;
             tilting postoperatively.&#xD;
&#xD;
          -  Patients with significantly reduced corneal endothelial cell density (of &lt; 1000&#xD;
             cells/mm2) preoperatively which may necessitate a corneal transplantation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alvin L Young</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prince of Wales Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ka Wai Kam</last_name>
    <phone>+852 3505 2879</phone>
    <email>dr.kwa.kam@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jackey Tse</last_name>
    <phone>+852 3505 2879</phone>
    <email>jackey@cuhk.edu.hk</email>
  </overall_contact_backup>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 14, 2020</study_first_submitted>
  <study_first_submitted_qc>August 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2020</study_first_posted>
  <last_update_submitted>August 14, 2020</last_update_submitted>
  <last_update_submitted_qc>August 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Kam Ka Wai</investigator_full_name>
    <investigator_title>Associate Consultant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Aphakia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

